# Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery

> **NCT03851172** · PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 75 (estimated)

## Conditions studied

- Cataract
- Miosis

## Interventions

- **DRUG:** Ketorolac Ophthalmic
- **DRUG:** Nepafenac Ophthalmic
- **DRUG:** Cyclopentolate Ophthalmic

## Key facts

- **NCT ID:** NCT03851172
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-03-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851172, "Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03851172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*